3-D Matrix
Self-Assembling Peptide Medical Devices & Biomaterial Research · Chiyoda, Tokyo
3-D Matrix develops biomaterials based on self-assembling peptide technology licensed from the Massachusetts Institute of Technology. Its PuraStat and PuraBond hemostatic products are supplied in prefilled syringes for surgical and endoscopic use. On contact with liquids such as blood, the peptide solution forms a hydrogel that covers the bleeding site.
The company is based in Chiyoda, Tokyo, with group offices in the United States, France and the United Kingdom. Research extends the peptide platform to regenerative medicine and drug delivery, including gastrointestinal mucosal healing and inflammatory bowel disease, while PuraMatrix is used as a scaffold in cell research.
0
open positions at 3-D Matrix
No live listings from 3-D Matrix right now — browse all Tokyo software jobs instead.